« Previous
Next »
Psychoneuroendocrinology
Volume 35, Issue 8
, Pages 1142-1147
, September 2010
Piloting the effective therapeutic dose of adjunctive selective estrogen receptor modulator treatment in postmenopausal women with schizophrenia
References
- . Adjunctive estrogen treatment in women with chronic schizophrenia: a double-blind, randomized, and placebo-controlled trial. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2003;27:1007–1012
- . Breast cancer after use of estrogen plus progestin in postmenopausal women. N. Engl. J. Med. 2009;360:573–587
- . Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N. Engl. J. Med. 1997;337:1641–1647
- . Neuroprotective actions of selective estrogen receptor modulators. Psychoneuroendocrinology. 2009;34:S113–S122
- . Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. JAMA. 1999;282:637–645
- . Gender differences in schizophrenia. Psychoneuroendocrinology. 2003;28:17–54
- . An animal model for the effects of estradiol on dopamine-mediated behavior: implications for sex differences in schizophrenia. Psychiatry Res. 1991;38:125–134
- . Raloxifene acutely reduces glutamate-induced intracellular calcium increase in cultured rat cortical neurons via inhibition of high-voltage-activated calcium current. Neuroscience. 2007;147:334–341
- . Estrogen in severe mental illness: a potential new treatment approach. Arch. Gen. Psychiatry. 2008;65:955–960
- . Hormone modulation: a novel therapeutic approach for women with severe mental illness. Aust. N. Z. J. Psychiatry. 2008;42:83–88
- . Selective estrogen receptor modulators: tissue actions and potential for CNS protection. CNS Drug Rev. 2002;8:309–330
- . Bone mineral density changes over a year in young females with schizophrenia: relationship to medication and endocrine variables. Schizophr. Res. 2007;93:136–143
- . Effects of estradiol and progesterone administration on human serotonin 2A receptor binding: a PET study. Biol. Psychiatry. 2000;48:854–860
- . Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression. Int. Clin. Psychopharmacol. 2008;23:84–87
- . Case report: raloxifene in postmenopausal women with psychosis: preliminary findings. Am. J. Geriatr. Psychiatry. 2003;11:697
- . Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial. Am. J. Psychiatry. 2005;162:683–690
PII: S0306-4530(10)00030-2
doi: 10.1016/j.psyneuen.2010.01.014
© 2010 Elsevier Ltd. All rights reserved.
« Previous
Next »
Psychoneuroendocrinology
Volume 35, Issue 8
, Pages 1142-1147
, September 2010
